Access to essential cancer medicines for children: a comparative mixed-methods analysis of availability, price, and health-system determinants in east Africa

• Published in: The lancet oncology Vol. 24; no. 5; pp. 563 - 576
• Main Authors: Petricca, Kadia, Kambugu, Joyce, Githang'a, Jessie, Macharia, William M, Njuguna, Festus, McLigeyo, Angela, Nyangasi, Mary, Orem, Jackson, Kanyamuhunga, Aimable, Laiti, Rehema, Katabalo, Deogratias, Schroeder, Kristin, Rogo, Khama, Maguire, Bryan, Wambui, Lucy, Nkurunziza, Jean N, Wong, Bryan, Neposlan, Joshua, Kilawe, Lilian, Gupta, Sumit, Denburg, Avram E
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2023; Elsevier Limited
• Subjects: Allopurinol; Bleomycin; Cancer; Child; Children; Comparative analysis; Cytotoxicity; Data collection; Drugs; Drugs, Essential; Etoposide; Health Services Accessibility; Hodgkin's lymphoma; Hospitals; Humans; Ifosfamide; Inventory; Investigations; Kenya; Low income groups; Lymphoma; Medicine; Methotrexate; Mixed methods research; Morphine; Neoplasms - drug therapy; Neoplasms - epidemiology; Oncology; Patients; Pediatrics; Pharmaceutical Preparations; Prices; Prospective Studies; Retinoblastoma; Tanzania - epidemiology; Uganda - epidemiology; Kenya; Uganda; Tanzania; Nairobi Kenya; Africa; Rwanda

Access to essential childhood cancer medicines is a core determinant of childhood cancer outcomes. Available evidence, although scarce, suggests that access to these medicines is highly variable across countries, particularly in low-income and middle-income countries, where the burden of childhood c...